Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
16 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/16/3083200/0/en/BlueSphere-Bio-Appoints-Alan-Korman-Ph-D-as-Chief-Scientific-Officer.html
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2930211/0/en/BlueSphere-Bio-Accepted-as-Member-of-Johnson-Johnson-Innovation-JLABS.html
25 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/25/2903924/0/en/BlueSphere-Bio-To-Partner-with-NMDP-BioTherapies-for-the-Company-s-First-In-Human-TCR-based-Product-Candidate-in-Combination-with-Allogeneic-Hematopoietic-Cell-Transplantation-Tria.html
04 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/04/2893172/0/en/BlueSphere-Bio-Establishes-Strategic-Collaboration-with-the-National-Cancer-Institute-to-Advance-Treatments-for-Rare-Respiratory-Disease.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2892552/0/en/BlueSphere-Bio-Announces-IND-Clearance-of-its-First-in-Human-Candidate-and-New-Cell-Therapy-Portfolio-for-High-Risk-Leukemia-Patients.html
30 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/30/2890893/0/en/BlueSphere-Bio-to-Present-Corporate-Update-and-Participate-in-a-Panel-Discussion-at-the-2024-BIO-International-Convention.html
ABOUT THIS PAGE